Evaluation of the Food and Drug Administration's General Market Youth Tobacco Prevention Campaign

ICR 201309-0910-006

OMB: 0910-0753

Federal Form Document

Forms and Documents
ICR Details
0910-0753 201309-0910-006
Historical Active
HHS/FDA 20492
Evaluation of the Food and Drug Administration's General Market Youth Tobacco Prevention Campaign
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 10/31/2013
Retrieve Notice of Action (NOA) 09/16/2013
In accordance with the terms of 5 CFR 1320, this ICR is approved for a period of three years. In subsequent waves of this study, we note that FDA may need to replace the stimuli as the ad campaign changes. These changes can be submitted as non-substantive changes. For all other changes, FDA should consult with OMB as early as possible.
  Inventory as of this Action Requested Previously Approved
10/31/2016 36 Months From Approved
70,618 0 0
12,612 0 0
0 0 0

The Food and Drug Administration (FDA) requests a 3-year Office of Management and Budget (OMB) approval to conduct in-person and Web-based surveys of youth in targeted areas in the United States. These surveys will be fielded for purposes of evaluating FDA's general market youth tobacco prevention campaigns. The primary outcome evaluation will consist of an initial baseline survey before the launch of each of three campaigns and three longitudinal follow-up surveys of those participants in 8-month intervals following the baseline data collection. In addition, a tracking survey to assess awareness of the campaigns and receptivity to campaign messages will occur in 8-month intervals throughout the data collection period. As part of the outcome evaluation study, a baseline survey will also be conducted with the parent or legal guardian of each youth baseline survey participant in order to collect data on household characteristics and media use. Data from this evaluation will be used to gauge campaign awareness and examine the statistical relationships between exposure to the campaigns and changes in outcome variables of interest.

PL: Pub.L. 111 - 31 31 Name of Law: Family Smoking Prevention and Tobacco Control Act
  
None

Not associated with rulemaking

  78 FR 37546 06/21/2013
78 FR 55725 09/11/2013
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 70,618 0 0 70,618 0 0
Annual Time Burden (Hours) 12,612 0 0 12,612 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new data collection.

$12,148,807
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
JonnaLynn Capezzuto 301 827-4659 jonnalynn.capezzuto@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/16/2013


© 2024 OMB.report | Privacy Policy